Shares in pharmaceutical company Elan surged in Dublin this morning after news of its inclusion in the Morgan Stanley Capital International Ireland Index.
Elan's main listing is in New York, but Morgan Stanley said it had now included its shares as liquidity in Europe had improved.
Analysts believe inclusion in the MSCI will help the stock by increasing its exposure to tracking funds.
